Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Beta cell-targeted glucokinase overexpression

ABSTRACT: Beta cell-targeted glucokinase overexpression

PROVIDER: PRJNA413133 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6130230_1.fastq.gz	Fastqsanger.gz
	SRR6130230_2.fastq.gz	Fastqsanger.gz
	SRR6130231_1.fastq.gz	Fastqsanger.gz
	SRR6130231_2.fastq.gz	Fastqsanger.gz
	SRR6130232_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Beta cell-targeted glucokinase overexpression

Project description:RNA sequecing of isolated mouse islets from C57BL/6J mice fed high fat diet following control or AAV-mIP2-GCK injection.

2018-05-23 | GSE104581 | GEO

RNAseq data from mouse beta-cells expressing mutant (GCK Y214C) versus wild-type Glucokinase

Project description:The goal of this study is to compare the transcriptome of mouse beta-cells expressing mutant constitutively active Glucokinase versus wild-type Glucokinase.

2016-10-15 | GSE86949 | GEO

Citrullination of glucokinase is linked to autoimmune diabetes

Project description:Inflammation, including reactive oxygen species and inflammatory cytokines in tissues amplify various post-translational modifications (PTMs) of self-proteins. A number of PTMs have been identified as autoimmune biomarkers in the initiation and progression of Type 1 diabetes (T1D). In this study, we have identified the citrullination of pancreatic glucokinase (GK) as a result of inflammation, triggering autoimmunity and affecting GK biological functions. Glucokinase is expressed in hepatocytes to regulate glycogen synthesis, and in pancreatic beta cells as a glucose sensor to initiate glycolysis and insulin signaling. We identify autoantibodies and autoreactive CD4+ T cells to glucokinase epitopes in the circulation of T1D patients and NOD mice. Finally, citrullination alters GK biologic activity (Km) and suppresses glucose-stimulated insulin secretion. Our studies define glucokinase as a T1D biomarker, providing new insights of how inflammation drives PTMs to create both neoautoantigens and affect beta cell metabolism.

2022-03-17 | PXD028825 | Pride

A stem cell model of diabetes due to glucokinase deficiency

Project description:Diabetes is a disorder characterized by loss of beta cell mass and/or beta cell function, leading to deficiency of insulin relative to metabolic need. To determine whether stem cell derived-beta cells faithfully reflect the phenotypes of a diabetic subject, we generated induced pluripotent stem cells from diabetic subjects (MODY2) with heterozygous loss-of-function of the gene encoding glucokinase (GCK). These stem cells differentiated into beta cells with an efficiency comparable to controls, and expressed markers of mature beta cells, urocotin-3 and zinc transporter 8 upon transplantation into mice. While insulin secretion in response to arginine or other secretagogues was identical to cells from healthy controls, GCK mutant beta cells required higher glucose levels to stimulate insulin secretion. Importantly this glucose-specific phenotype was fully reverted upon gene sequence correction by homologous recombination. Our results demonstrate that stem cell-derived beta cells reflect beta cell-autonomous phenotypes of MODY2 subjects, providing a platform for mechanistic analysis of specific genotypes on beta cell function. Induced pluripotent stem cells with munations in the glucokinase gene were differentiationed into pancreas cells using published protocol (D'Amour et al, 2006) with certain modifications. 1 million cells(fibroblast or stem cells or differentiated pancreatic cells) was used for RNA extraction and labeling using the Illumina total prep RNA amplification kit.

2013-04-05 | E-GEOD-45777 | biostudies-arrayexpress

A stem cell model of diabetes due to glucokinase deficiency

2013-04-05 | GSE45777 | GEO

Molecular Profiling of glucokinase-expressing cells from mouse hypothalamus

Project description:Analysis of genes from glucokinase-expressing cells following immunoprecipitation of hypothalamic EGFP-tagged L10 ribosomal protein from Glucokinase-cre/Elongation factor 1 alpha 1 - lox stop lox - EGFPL10 mice

2013-09-13 | GSE49868 | GEO

Activation of Wnt/β-catenin Signaling Blocks Monocyte-Macrophage Differentiation Through Antagonizing PU.1-Targeted Gene Transcription

Project description:We have shown that β-catenin overexpression induced blockage of monocyte-macrophage differentiation by inhibiting PU.1-targeted gene transcription including Egr2 expression in myeloid progenitor cells. Our results suggest that compromised PU.1-targeted gene transcription induced by β-catenin overexpression, at least partially, may mediate a pathogenic role of β-catenin in myeloid leukemia.

2016-04-06 | GSE79932 | GEO

Genes induced by Oxi-beta overexpression in dopaminergic neuronal cell SN4741

Project description:To identify genes regulated by Oxi-beta, differential gene chip analysis was perfomed. And the greatest upregulation (about 25-fold) of FBXW5 mRNA was observed in response to Oxi-beta overexpression in SN4741 dopaminergic neuronal cells Total RNAs obtained from subjected to overexpression of Oxi-beta for 12 hours compared to control SN4741 cells at 0 hr.

2013-06-05 | E-GEOD-47634 | biostudies-arrayexpress

Molecular Profiling of glucokinase-expressing cells from mouse hypothalamus

2013-09-13 | E-GEOD-49868 | biostudies-arrayexpress

Targeted pharmacological therapy restores β-cell function for diabetes remission

Project description:Targeted pharmacological therapy restores β-cell function for diabetes remission

| PRJNA528110 | ENA